BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8269199)

  • 1. Diagnostic value of left ventricular dyssynergy patterns in ischemic and non-ischemic cardiomyopathy.
    Nanna M; Palma A; Rajachandran M; Maher M; Shen Z; Sonnenblick EH; LeJemtel TH
    Coron Artery Dis; 1993 Oct; 4(10):919-27. PubMed ID: 8269199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
    Schinkel AF; Poldermans D; Rizzello V; Vanoverschelde JL; Elhendy A; Boersma E; Roelandt JR; Bax JJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):385-90. PubMed ID: 14762345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial segmental thickness variability on echocardiography is a highly sensitive and specific marker to distinguish ischemic and non-ischemic dilated cardiomyopathy in new onset heart failure.
    Katikireddy CK; Acharya T
    Int J Cardiovasc Imaging; 2019 May; 35(5):791-798. PubMed ID: 30594979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.
    Collins J; Sommerville C; Magrath P; Spottiswoode B; Freed BH; Benzuly KH; Gordon R; Vidula H; Lee DC; Yancy C; Carr J; Markl M
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Doughty RN; Whalley GA; Gamble G; MacMahon S; Sharpe N
    J Am Coll Cardiol; 1997 Apr; 29(5):1060-6. PubMed ID: 9120160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volume overload modulates effects of cardiac resynchronization therapy independently of myocardial reperfusion: results of the RESYNC study.
    Gimelli A; Stanislao M; Valle G; Frumento P; Zanco P; Ometto R; Inglese E; Martino G; Startari U; Bertelli P; Marzullo P
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):575-81. PubMed ID: 17667027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of guideline-recommended versus non-guideline-recommended β-blocker and Doppler echocardiographic parameters on 1-year mortality in Thai ischemic cardiomyopathy patients: A prospective multicenter registry.
    Wongpraparut N; Siwamogsatham S; Thongsri T; Ngamjanyaporn P; Phrommintikul A; Jirajarus K; Tangcharoen T; Bhumimuang K; Kaewsuwanna P; Krittayaphong R; Pongakasira R; White HD
    BMC Cardiovasc Disord; 2020 Jan; 20(1):8. PubMed ID: 31918676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of regional systolic function in hypertrophic cardiomyopathy and hypertensive heart disease: a three-dimensional echocardiographic study.
    Frielingsdorf J; Franke A; Kühl HP; Rijcken E; Krebs W; Hess OM; Flachskampf FA; Hanrath P
    J Am Soc Echocardiogr; 1998 Aug; 11(8):778-86. PubMed ID: 9719089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of coronary sinus tributaries in ischemic cardiomyopathy: An insight from multidetector computed tomography cardiac venographic study.
    Boonyasirinant T; Halliburton SS; Schoenhagen P; Lieber ML; Flamm SD
    J Cardiovasc Comput Tomogr; 2016; 10(2):156-61. PubMed ID: 26857422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting long-term functional results after myocardial revascularization in ischemic cardiomyopathy.
    Luciani GB; Montalbano G; Casali G; Mazzucco A
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):478-89. PubMed ID: 10962408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of "inotropic reserve" to functional capacity in heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Gudjonsson T; Rahko PS
    Am J Cardiol; 2002 May; 89(9):1057-61. PubMed ID: 11988195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midterm clinical and echocardiographic results and predictors of mitral regurgitation recurrence following restrictive annuloplasty for ischemic cardiomyopathy.
    Onorati F; Rubino AS; Marturano D; Pasceri E; Santarpino G; Zinzi S; Mascaro G; Renzulli A
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):654-62. PubMed ID: 19698852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel, innovative ovine model of chronic ischemic cardiomyopathy induced by multiple coronary ligations.
    Schmitto JD; Mokashi SA; Lee LS; Laurence R; Schotola H; Coelho-Filho O; Rajab TK; Kwong R; Bolman RM; Quintel M; Cohn LH; Chen FY
    Artif Organs; 2010 Nov; 34(11):918-22. PubMed ID: 21137156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial revascularization in patients with ischemic cardiomyopathy: functional observations.
    Salati M; Lemma M; Di Mattia DG; Danna P; Cialfi A; Salvaggio A; Santoli C
    Ann Thorac Surg; 1997 Dec; 64(6):1728-34. PubMed ID: 9436563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential diagnosis of congestive cardiomyopathy and myocardial ischemia: two-dimensional echocardiography has a limited value].
    Díaz RA; Nihoyannopoulos P; Oakley CM
    Rev Med Chil; 1991 Jul; 119(7):772-7. PubMed ID: 1844752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Localized disorders of left ventricular wall motion in congestive cardiomyopathy (author's transl)].
    Takahashi M; Fujisawa A; Nakamura M; Kannagi T; Kawai C
    J Cardiogr; 1981 Dec; 11(4):1241-51. PubMed ID: 7345128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does resting two-dimensional echocardiography identify patients with ischemic cardiomyopathy and low likelihood of functional recovery after coronary revascularization?
    Rizzello V; Bax JJ; Schinkel AF; Boersma E; Bountioukos M; Vourvouri EC; Crea F; Biagini E; Elhendy A; Roelandt JR; Poldermans D
    Coron Artery Dis; 2004 Aug; 15(5):269-75. PubMed ID: 15238824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular apical wall motion abnormality is associated with lack of response to cardiac resynchronization therapy in patients with ischemic cardiomyopathy.
    Buch E; Lellouche N; De Diego C; Vaseghi M; Cesario DA; Fujimura O; Wiener I; Child JS; Boyle NG; Shivkumar K
    Heart Rhythm; 2007 Oct; 4(10):1300-5. PubMed ID: 17905335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial viability and cardiac dyssynchrony as strong predictors of perioperative mortality in high-risk patients with ischemic cardiomyopathy having coronary artery bypass surgery.
    Maruskova M; Gregor P; Bartunek J; Tintera J; Penicka M
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):62-8. PubMed ID: 19577058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurohormonal response to left ventricular reconstruction surgery in ischemic cardiomyopathy.
    Schenk S; McCarthy PM; Starling RC; Hoercher KJ; Hail MD; Ootaki Y; Francis GS; Doi K; Young JB; Fukamachi K
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):38-43. PubMed ID: 15224019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.